Seven Grand Managers’s Scribe Therapeutics SCTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SCTX
BBA
Seven Grand Managers's SCTX Position: Q3 2026 in Review
Seven Grand Managers opened a new position in Scribe Therapeutics (SCTX) in Q3 2026: 10,000 shares worth $184K. The stake represents 0.01% of the portfolio and ranks #152 among its holdings.
63 funds tracked by Wall St. Rank hold SCTX as of Q3 2026.
- Seven Grand Managers held 10,000 shares of Scribe Therapeutics worth $184K as of Q3 2026.
- Scribe Therapeutics was a new Seven Grand Managers position in Q3 2026.
- Scribe Therapeutics made up 0.01% of Seven Grand Managers's portfolio in Q3 2026, its #152 holding.
- 63 funds tracked by Wall St. Rank held Scribe Therapeutics as of Q3 2026.
Based on Seven Grand Managers's 13F filing for Q3 2026, filed 16 Nov 2026.